Stefan Duerr, sr. director, head of the Cenduit Drug Supply Center of Excellence, and IQVIA business, explains how a flexible and innovative approach to Interactive Response Technology (IRT) can help navigate today's clinical trial landscape.
Brigitte Pica2 Shutterstock